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Abstract
Prostate epithelial cells from both normal and cancer tissues, grown in three-dimensional (3D) culture as spheroids,
represent promising in vitro models for the study of normal and cancer-relevant patterns of epithelial differentiation. We
have developed the most comprehensive panel of miniaturized prostate cell culture models in 3D to date (n = 29), including
many non-transformed and most currently available classic prostate cancer (PrCa) cell lines. The purpose of this study was to
analyze morphogenetic properties of PrCa models in 3D, to compare phenotypes, gene expression and metabolism
between 2D and 3D cultures, and to evaluate their relevance for pre-clinical drug discovery, disease modeling and basic
research. Primary and non-transformed prostate epithelial cells, but also several PrCa lines, formed well-differentiated round
spheroids. These showed strong cell-cell contacts, epithelial polarization, a hollow lumen and were covered by a complete
basal lamina (BL). Most PrCa lines, however, formed large, poorly differentiated spheroids, or aggressively invading
structures. In PC-3 and PC-3M cells, well-differentiated spheroids formed, which were then spontaneously transformed into
highly invasive cells. These cell lines may have previously undergone an epithelial-to-mesenchymal transition (EMT), which is
temporarily suppressed in favor of epithelial maturation by signals from the extracellular matrix (ECM). The induction of lipid
and steroid metabolism, epigenetic reprogramming, and ECM remodeling represents a general adaptation to 3D culture,
regardless of transformation and phenotype. In contrast, PI3-Kinase, AKT, STAT/interferon and integrin signaling pathways
were particularly activated in invasive cells. Specific small molecule inhibitors targeted against PI3-Kinase blocked invasive
cell growth more effectively in 3D than in 2D monolayer culture, or the growth of normal cells. Our panel of cell models,
spanning a wide spectrum of phenotypic plasticity, supports the investigation of different modes of cell migration and
tumor morphologies, and will be useful for predictive testing of anti-cancer and anti-metastatic compounds.
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Introduction
Two-dimensional (2D) monolayer cell cultures represent highly
reductionist models of epithelial cells and epithelial cancers, due to
the loss of physiological extracellular matrix (ECM) on artificial
plastic surfaces, and high serum concentrations. Consequently,
cells lose relevant properties, such as differentiation, polarization,
cell-cell communication and extracellular matrix contacts, while
wound healing, inflammatory processes, and hyper-proliferation
are artificially promoted. In monolayer culture of prostate cancer
(PrCa) lines, the homeostasis of undifferentiated tumor stem cells
through basal, transit-amplifying and terminally differentiated,
hormone-sensitive luminal cells depends on cell culture conditions,
calcium and serum concentration [1,2], and only poorly represents
tumor cell biology in vivo. The lack of a relevant basal lamina (BL),
defective ECM deposition, and missing stromal or myoepithelial
components [3] further contribute to the artificial nature. As a
result, the most effective small molecule inhibitors in monolayer
cultures are chemotherapeutic drugs that target proliferation and
mitosis. This imbalance contributes to the poor predictive value of
compound efficacies between in vitro and in vivo experiments. Drug
action that relates to cell-cell interaction, maturation, epithelial to
mesenchymal transition (EMT) and cancer stem cells (CSC) is
likely to go undetected. Both 3D architecture and the ECM exert
strong effects on drug efficacy [4]. Glandular epithelial cancer cells
rapidly adapt to different microenvironments and can dynamically
switch between alternative pathways that regulate proliferation,
differentiation and survival.
The development of drug resistance or failure to respond to
chemotherapeutic drugs also requires appropriate cell culture
models. Drug resistance is often attributed to the cancer stem cell
(CSC) hypothesis: anti-mitotic cancer drugs spare the slow
proliferating, tumor-regenerating stem- or progenitor cells [5–7],
which eventually re-constitute the tumor mass. This may be
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concomitant with EMT [7–10] and increased metastatic potential
[8]. The search for anti-cancer drugs has thus entered a new stage
in which researchers increasingly utilize organotypic model
systems to more directly explore drug targets on multicellular
organoids, often enriched for stem cells [11]. Appropriate in vitro
experimental models suitable for the analysis of CSC homeostasis,
EMT, invasion and metastasis, are becoming increasingly relevant
for cancer drug discovery. These should also be cost effective and
provide sufficient throughput for high content screening.
The culture of glandular epithelial (cancer) cells in purified ECM,
such as collagen, hydrogels or Matrigel, was established over two
decades ago [12]. Matrigel represents a reconstituted, laminin-rich
basement membrane, which supports processes such as cell polarity,
cell-cell- and cell-matrix interaction, and re-expression of differen-
tiation markers even in transformed lines [13]. Mammary and
prostate epithelial cells form spheroids, referred to as mammo-
spheres [14] or prostaspheres [15], respectively. Normal prostate
epithelial cells differentiate into well-polarized hollow spheroids, a
hallmark of functional, glandular epithelial cells. The same
microenvironment also supports cell migration, branching and
the formation of characteristic acini [16,17]. In contrast, tumor cells
usually show a defective differentiation program, and form atypical
spheroids with disorganized architecture, as demonstrated most
prominently for breast cancers [18–20]. Gene expression patterns
of spheroids were demonstrated to correlate with the characteristic
phenotypes formed in 3D cultures [19,20] and overall differenti-
ation and aggressive potential of cancers [21,22]. Similar to normal
epithelial cells, PrCa cells can also actively invade the surrounding
matrigel, although their mode of migration is different from the
normal, collective sheet or tube migration patterns observed in
branching of normal cells. The phenotype of cancer invasion
depends on composition and density of the ECM, and can vary
from amoeboid blebbing, mesenchymal fibroblast-like motility and
multicellular streaming or chain migration [23,24]. Naturally, the
invasive potential also depends on the genetic background of the
PrCa cells and their (usually compromised) capability to engage in
stringent epithelial cell-cell contacts. Mammary and other epithelial
cancer cells form cylindrical, spindle-like cells with the potential to
contract and elongate, supporting migration through the surround-
ing ECM mesh. Much less is known about PrCa. Invasion is
assisted by proteolytic processes and proteases such as cathepsins
[25], matrix metalloproteinases (MMPs [24]), soluble factors
secreted by fibroblasts or the presence of fibroblasts themselves
[26,27], and other factors such as fibronectin and lysyl oxidases
[26]. In this regard, 3D models of tumor-cell invasion [28]
represent cellular dynamics and architecture of tumors far better
than 2D monolayer cultures in which cells spread and glide across
the plastic surface. The potential to undergo an EMT and to
acquire mesenchymal migration modes is another parameter
postulated to contribute to breast-and PrCa invasion and motility
[29].
Furthermore, it is unclear if PrCa spheroids, particularly when
grown in lrECM, show enrichment of CSC populations (which is
often associated with an EMT), or develop resistance against
chemotherapeutic agents and ionizing radiation [30,31]. At the
least, involvement of CSC’s or EMT would be expected to display
a very different dynamics in differentiating 3D cultures in LrECM,
compared to floating prostaspheres and 2D monolayer conditions
[32]. Last not least, cell culture models for tumor cell invasion are
currently restricted to a few widely used, potentially artificial assays
(transwell invasion assays; scratch-wound migration assays). Since
invasion is fundamentally different under 3D conditions, any
representative 3D invasion models represent a veritable novelty
[26, 28, and 33].
We report here the development and morphological character-
ization of miniaturized 3D cell culture model systems, utilizing a
panel of 29 prostate cell lines. A selection of the most
representative lines were then further characterized by genome-
wide transcriptome analyses and systems biology to identify key
pathways, signaling molecules, gene networks, and putative drug
targets critical for growth and invasion of malignant PrCa cells.
Furthermore, bioinformatic image analysis tools to quantify
dynamic phenotypic features such as invasive structures, spheroid
shape or drug responses have been developed.
Materials and Methods
Cell lines and monolayer cultures
Cell lines were purchased from ATCC or requested from the
originator laboratories (Table S1). Normal epithelial cells and
derivatives (PrEC, EP156T, RWPE-1, RWPE-2, RWPE-2/w99,
WPE1-NB14, PWR-1E, PZ-HPV-7 and CA-HPV-10) were
cultured in Keratinocyte Serum-Free Medium (KSFM, Gibco),
supplemented with 12.5 mg/l bovine pituitary extract and
1.25 mg/l EGF. For 3D cultures, 2% fetal bovine serum (FBS,
Gibco) were added. Most PrCa lines were cultured in RPMI-1640
(Sigma-Aldrich), supplemented with 10% FBS. MDA-PCa-2b and
NCI-H660 cells were cultured in Ham’s F12 medium (Gibco) with
20% FBS, 25 ng/ml choleratoxin, 10 ng/ml EGF, 5 mM
phosphoethanolamine, 0.1 ng/ml hydrocortisone, 45 nM selenic
acid and 5 mg/ml insuline (all from SIGMA). All cells were
propagated at 37uC in standard cell culture conditions (5% CO2,
95% humidity). Identity of cell lines was confirmed by arrayCGH
(comparative genomic hybridization) on Agilent 244 k human
genome arrays, after 10–15 passages cells were discontinued.
Miniaturized 3D cultures. Cells were embedded between
two layers of Matrigel on uncoated Angiogenesis m-slides (Ibidi
Gmbh, Germany): bottom wells were filled with 10 ml of Matrigel/
culture medium (1:1; 50%) and polymerized at 37uC for 30 min.
Cells were then seeded at 20.000 cells/ml density (,1000 cells/
well). After attachment (1–2 hours at 37uC), cells were covered
with a second layer of Matrigel/culture medium (1:4, 25%),
allowed to polymerize overnight at 37uC. Cell culture medium was
changed every second day.
3D bulk cultures for RNA extraction. Prostaspheres were
cultured in Millicell hanging cell culture inserts with 1.0 mm PET
transparent membranes (Millipore) on 6-well plates (Costar).
Membranes were pre-coated with Matrigel/medium (1:1) and
incubated at 37uC for 1 h, to prevent attachment to the membrane.
Cell suspension was mixed 1:4 with Matrigel, transferred to the
coated well, and polymerized overnight at 37uC. Cells were fed
every other day with fresh medium from beneath.
Cell fixation, immunofluorescence labeling and
imaging. Miniaturized 3D cultures were fixed within
microwells, using 4% paraformaldehyde, supplemented with
0.8% Triton X-100 (Sigma-Aldrich), 5 mM EGTA and 1 mM
MgCl2 for 15–20 minutes at RT. Fixed cultures were washed 3
times with PBS and blocked for 1 h with 20% horse serum.
Cultures were incubated overnight at 4uC with primary antibodies
(listed in Table S2), washed with PBS, and incubated at room
temperature for 4 h with secondary antibodies and Hoechst
nuclear stain (1:5000).
3D structures were stained with Calcein AM live cell dye
(Invitrogen). Confocal three-dimensional images were taken by
using Zeiss Axiovert 200 M with spinning disc confocal unit
Yokogawa CSU22 and a Zeiss Plan-Neofluar 56 objective. Z-
stacks were acquired with a step-size of 19 mm. Intensity
projections were created by SlideBook 4.2.0.7 and NIH ImageJ
3D Models of Prostate Cancer
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(http://rsbweb.nih.gov/ij/), further analyzed with VTT Acca
software (sensitivity 10; threshold 5, structures less than 500 pixels
in area/size filtered out). Box plots were visualized with R. 20x
phase-contrast time lapse images were acquired with Incucyte
(Essen instruments), pre-processed with ImageJ and analyzed with
VTT Acca (sensitivity 30; threshold 5, structures less than 1000
pixels in area filtered out).
RNA extraction and microarrays. 3D bulk cultures were
washed with ice-cold PBS, membranes excised with a scalpel, and
spheroids transferred into 6-well plates. Gels were mixed
vigorously with 9 ml of 5 mM EDTA in PBS, transferred into
15 ml Falcon tubes, and incubated on a tabletop rocker for 45 min
to detach from the Matrigel. Prostaspheres were sedimented by
centrifugation and lysed with RLT buffer (Qiagen). Cells
propagated in monolayer were lysed at 90% confluence, directly
from 10 cm cell culture dishes using RLT buffer. Total RNA
(from biological replicates) was extracted with RNeasy Mini kit
(Qiagen), according to the manufacturer’s protocol. 300 ng RNA
was amplified with Ambion’s Illumina TotalPrep RNA
Amplification kit. IVT reaction was performed overnight
(,16 h) to yield sufficient biotinylated cRNA. RNA and cRNA
concentrations were measured with a nanodrop ND-1000, overall
quality was monitored with BioRad’s Experion electrophoresis
station. 750 ng cRNA were hybridized on Illumina’s Sentrix
HumanRef-8 v3 BeadChips, at 58uC overnight. Hybridized
cRNA was detected with 1 mg/ml Cyanine3-streptavidine (GE
Healthcare Biosciences), and arrays scanned with Illumina
BeadArray Reader. Data were quality checked and extracted
using Illumina GenomeStudio software, without normalization or
background subtraction.
Microarray data analysis. Raw microarray data were
quantile-normalized, using the bioconductor R package
‘‘beadarray’’. Normalized data were further processed using a
variance and intensity filter. Statistical analysis of differential gene
expression was performed using the limma and lumi R/
Bioconductor packages. The threshold for differential expression
was q,0.05 after a Benjamini-Hochberg multiple testing
correction. Normalized Illumina gene expression data of the
entire panel of experiments have been submitted to GEO (Gene
expression Omnibus) as study GSE19426.
Data were then used in two different modes: to evaluate relative
changes of gene expression between 2D and 3D experiments, or
different time points in 3D culture, mean normalized values in 3D
were subtracted from mean values of replicates in 2D monolayer
culture and ratios calculated. Log(2) transformed 2D/3D ratios
were then utilized for clustering and heatmap generation (Cluster
2.11 and TreeView 1.60, Stanford University), and gene ontology
analysis (GO; DAVID, http://david.abcc.ncifcrf.gov/). K-Means
clustering was used to draw representative heatmaps based on 2D/
3D ratio data, generating 12 nodes (100 iterations). The Gene Set
Analysis (GSA) package in R was used to define significantly
enriched gene categories, here the ‘‘Maxmean’’ statistics was used
to calculate enrichment scores, and permutation based p-values
were derived from 1000 bootstrap replicates. A false discovery rate
(FDR) correction was also applied as a measure of relevance. Gene
sets utilized for analysis were obtained from the Molecular
Signatures Database (MSigDB, Broad Institute), including posi-
tional, curated, co-expression neighbourhood, GO, and evolu-
tionarily conserved transcription-factor targets.
Secondly, normalized but otherwise un-processed gene expres-
sion data were utilized to define gene signatures that correlate with
phenotypic characteristics (round/normal, mass, stellate pheno-
type). Principal component analysis (PCA) and plotting of
informative genes correlating with spheroid morphologies were
performed based on specialized R scripts. Genes representing the
largest percentage of variance were selected based on ANOVA.
Ingenuity Pathway Analysis (IPA) and compound
selection. Differentially expressed gene clusters (2D/3D ratios)
were uploaded to IPA to perform gene network analyses and
identification of potentially informative central ‘‘hub’’ genes.
Specific small molecule inhibitors against certain hubs or hub
genes and pathways were acquired from TOCRIS and SIGMA-
Aldrich (see below). Additional and independent sources of drug/
target information were also utilized for the same purpose
(DrugBank; http://www.drugbank.ca; Matador http://matador.
embl.de).
RT-PCR validation. 2 mg of total RNA were reverse
transcribed with Invitrogen Superscript II reverse transcriptase
in 50 ml. cDNAs were diluted 1/10. QRT-PCR was performed in
triplicates with the 7900HT Fast Sequence Detection System
(Applied Biosystems) in 96-well or 384-well plate format, 8 ml/
well. PCR primers and probes were designed based on the Roche
Universal Probe Library, oligonucleotides were ordered from
Sigma-Aldrich. Primers were used at 300 nM, probes at 100 nM
concentration; with 2x TaqManH Universal PCR Master Mix.
PCR runs were analyzed using Applied Biosystems SDS software.
Protein lysate microarrays (LMA). Prostaspheres were
collected on days 3, 6, 8, 10 and 14; according to the following
protocol: microwells were washed with PBS, Matrigel mixed with
ice-cold 5 mM EDTA in PBS, transferred into v-bottom 96-well
plate (Greiner), and incubated on ice in a tabletop-shaker for 30
minutes. Spheres were sedimented by centrifugation and lysed in
LMA-buffer (0.2% SDS, 100 mM Tris, 10 mM DTT). Monolayer
cells were harvested in LMA-buffer at 90% confluence in 10 cm
plates. For each time point, two biological replicates were printed
on a single array. Printing, staining, scanning, background
subtraction, normalization relative to b-actin signal, and data
analyses were performed as described previously [34].
Western blotting. Protein samples from culture wells were
collected as described from microwell plates, and lysed in WB-
buffer (25 mM Hepes pH 7.5, 100 mM NaCl, 5 mM EDTA
pH 8.3, 0.5% Triton X-100, 20 mM b-glycerophosphate, 100 mM
orthovanadate, 0.5 mM PMSF and 1 mM DTT). Protein
concentration was measured by Bradford assay, and proteins
separated by SDS-PAGE with precast PAGEr gels (Lonza),
transferred on Protran nitrocellulose transfer membrane
(Whatman), and blotted with the primary antibodies listed in
Table S3. Multiplex incubation with three antibodies was used to
accommodate for the small total amount of proteins extracted
from miniaturized cultures. Antibodies were detected with Alexa
infrared dye-conjugated secondary antibodies (Invitrogen), and
membranes scanned with the Odyssey Infrared Imaging System
(LI-COR).
Drug treatments in 3D. compounds were ordered from
SIGMA or Tocris Inc., and dissolved in the appropriate vehicle
(DMSO, Ethanol, 1xPBS) according to manufacturer’s
instructions. Recombinant human chemokines, cytokines, and
function-blocking antibodies were ordered from R&D Systems.
Drugs were prepared as 10 mM stock solutions, stored at 220.
Most chemokines and peptides were diluted to 1 mg/ml stock
solutions. Dilution to working solutions was done immediately
prior to treatment. Drugs were added after a 4 day period, during
which spheroids develop, and maintained for up to 7 days. Drug
concentrations were selected according to half maximal inhibitory
concentration (IC50), known for most compounds. All treatments
were performed in triplicates. Spheroids were monitored in real-
time by live-cell imaging (Incucyte, Essen Instruments; 10x
objective), acquiring 1 image/h.
3D Models of Prostate Cancer
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Cell proliferation assays. Cells were seeded on 384-well
plates 24 h before the drugs were added. After 72 h the number of
living cells was assessed with CellTiter BlueH Cell Viability Assay
(Promega) according to manufacturer’s protocol. Fluorescent
signal was quantified with EnVision Multilabel Plate Reader
(Perkin Elmer).
Results
Normal prostate epithelial cells and PrCa lines form
characteristic morphologies in Matrigel.
Normal prostate and prostate cancer (PrCa) cell lines fail to
differentiate and form multicellular structures in purely collagen-
rich extracellular matrix (Figure S1). In collagen, both normal-
and tumor cells formed only loose aggregates, with poor or no cell-
cell contacts, often displaying a fibroblast-like growth pattern. In
contrast, Matrigel strongly supports both growth and differentia-
tion of normal and PrCa spheroids. Matrigel has profound effects
on all cell lines tested and, with few exceptions; formation of
relevant multicellular structures is supported. Spheroid formation
in Matrigel was typically initiated by single cells. The spheroids
formed in Matrigel generally fell into four morphological
categories, adapted from [19,35] (Figure 1; Figure S2).
Branching/Round phenotype. Normal primary prostate
epithelial (PrECs) and non-transformed lines such as RWPE-1
and EP156T cells formed round spheroids after 6–10 days in
culture (Figure 1). Normal PrECs and in-vitro immortalized cell
lines such as RWPE-1 and PWR-1E cells simultaneously formed
branching acinar and round spheroid structures, actively migrate
into the surrounding ECM in the form of large cell aggregates
(Figure 2a–d). EP156T cells showed no or few branching
structures. Round structures generally developed a robust basal
lamina (BL), encapsulating both spheroids and acinar structures
(Figure 2, Figure S2, Figure 3g–m). Surprisingly, the tumor lines
DU145, PC-3 and PC-3M cells also formed round and well
differentiated, polarized spheroids (Figure 2e), surrounded by a
complete BL, and frequently containing a lumen (PC-3;
Figure 3e+r). Additionally, PC-3 spheroids often contained an
internal cell mass reminiscent of structures seen in PIN (prostate
intraepithelial neoplasias). Immune staining for tight-junction
proteins such as ZO-1 (not shown) and F-actin (Figure 3a–c)
demonstrated generally very robust cell-cell contacts and cell
Figure 1. Representative phase contrast images of spheroids formed in 3D Matrigel culture. Most structures fell into the categories
round, mass, stellate, or grape-like. Some cell lines failed to form spheroids in Matrigel but persisted as single live cells for up to two weeks (single
phenotype). Most spheroids were imaged at days 9–10 after inoculation. PC-3 spheroids, shown as round phenotype at day 9, undergo a
metamorphosis to invasive/stellate phenotype at day 13. The same occurs to PC-3M at an earlier time point (day 5–8).
doi:10.1371/journal.pone.0010431.g001
3D Models of Prostate Cancer
PLoS ONE | www.plosone.org 4 May 2010 | Volume 5 | Issue 5 | e10431
3D Models of Prostate Cancer
PLoS ONE | www.plosone.org 5 May 2010 | Volume 5 | Issue 5 | e10431
polarization in round spheroids formed by both normal and
tumor cells.
Mass phenotype. the majority of PrCa (LNCaP, 22rV1,
MDA-PrCa 1, UM-SCP1, CWR-r1, LAPC-4) and two in vitro
transformed lines (PWR-1E, RWPE-2) generated large, irregular
spheroids with often incomplete or missing BL, also lacking a
hollow lumen (Figure 3d+k). PWR-1E was the only mass-
phenotype cell line capable of branching/acinar morphogenesis
(Figure 2d). The luminal keratins KRT8 and KRT18 were always
strongly expressed (Table S3). Cell-cell contacts, maturation and
polarization were generally less pronounced, compared to round
spheroids, reflected in the often kidney shaped irregular spheroids
(Figure 1). Mass phenotype structures did usually not show
invasion of the lrECM; however, formation of filopodia or
pseudopodia was consistently observed in the 22rV1 and
occasionally in the LNCaP and RWPE-2 cell lines. In LNCaP
spheroids, cells were frequently observed to leave the spheroid
structures at sites of incomplete BL coverage (Figure S2).
Grape-like phenotype. Only one cell line, 1013L,
consistently formed loose clusters of cells with particularly poor
cell-cell contacts, lacking any BL. LAPC-4 cells formed both mass
and grape-like structures. No invasive properties were observed in
these cell lines.
Stellate ‘‘invasive’’ phenotype. The in vitro transformed
cell lines RWPE-2/w99, WPE-1/NB14, and the tumor lines
ALVA-31 and ALVA-41 formed stellate or invasive structures,
Figure 2. Phase contrast and confocal laser scanning microscopy of various prostate cells and cell lines grown in Matrigel,
illustrating the phenotypic differences between branching phenotype typically observed in several non-transformed cell lines, and
the stellate/invasive phenotype restricted to tumor cells. A) Phase contrast image of branching structures formed by RWPE-1 cells, B) acinar
structure formed by RWPE-1 stained with an antibody against laminin B1. C) Branching or cluster-like structures formed by primary prostate epithelial
cells (PrEC). D). Mixed branching and mass phenotype structures, formed by PWR-1E cells. E) Round structures formed by PC-3 cells at day 9, live cell
staining with calcein. F) Morphological transformation of round spheroids into invasive structures at day 13. G) Phase-contrast image of invasive PC-3
structures around day 13. H). Staining of PC-3 filopodia with an antibody specific for the active form of integrin beta 1 (ITGB1), illustrating dense
decoration of spindle-like cell structures.
doi:10.1371/journal.pone.0010431.g002
Figure 3. Representative immune cytochemistry staining of spheroids structures, grown for 9 or 14 days in Matrigel, using
antibodies against the basal-lamina component laminin beta 1 (LAMB1), and the mesenchymal markers vimentin (VIM), and
fibronectin (FN). Alexa488-labeled phalloidin was used to detect F-actin and Hoechst stain to label nuclei (blue). RWPE1, DU145 and PC3 cells show
expression of EMT-related mesenchymal markers, regardless of phenotype (PC-3 cells; round at day 9, stellate at day 14).
doi:10.1371/journal.pone.0010431.g003
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characterized by spindle-like filopodia (Figure 2g) and the rapid
migration of chains of cells through the surrounding ECM.
Invasive structures formed were almost exclusively multicellular
and showed a chain-like invasion mode. Fibroblast-like,
mesenchymal invasion of single cells was observed only
occasionally. The in vitro transformed lines RWPE-2, RWPE-2/
w99 and WPE1/NB14 simultaneously formed stellate structures
and round spheroids, indicating heterogeneous composition of
these cell lines. Of these, RWPE-2/w99 represented the cell line
with the most consistent stellate phenotype, and was selected for
further experiments. Immortalized prostate stromal cells (WPMY-
1) and tumor-derived, primary stromal cells (not shown) also
formed stellate-like structures, however lacking rapid motility and
invasive properties.
Invasive switch. Round and well differentiated, polarized
spheroids were formed by PC-3 and PC-3M cells, but underwent a
spontaneous transformation towards invasive morphology around
10–13 and 6–8 days in 3D, respectively (Figure 2e+f, supplemental
invasion Movie S1). The onset of morphological transformation into
the stellate, invasive phenotype was dependent on cell density.
Transformation could be temporarily delayed and even partially
reverted upon feeding fresh medium, but eventually continued to
progress until all structures were thoroughly transformed and only
stellate structures remained (Figure 2g). Invasive structures and
filopodia formed even prior to invasion strongly expressed the active
form of the laminins-receptor integrin beta 1, indicating strong
contacts to the extracellular matrix as a prerequisite for invasive
processes (Figure 2h). Simultaneously, the BL of transformed
structures becomes increasingly fuzzy and disintegrated
(Figure 3m). Strong expression of mesenchymal markers Vimentin
VIM and Fibronectin FN1 (Figure 3o–y), observed in non-invasive
RWPE-1 (heterogeneous) and DU145, but also in PC-3 cells, did
not correlate with the stellate phenotype. Furthermore, expression of
VIM and FN1 were not increased after the invasive transformation
of PC-3 and PC-3M cells (Figure 3s+y)
‘‘Single’’ phenotype. Some cancer lines (VCaP, DuCaP,
NCI-H660 and MDA-PCa 2b) failed to form spheroids, but
persisted as single cells (‘‘single’’ or ‘‘singular phenotype’’) for up to 2
weeks. Interestingly, all of these cell lines were positive for ETS-
transcription factor fusion events or rearrangements (TMPRSS2-
ERG in H660, VCaP and DuCaP, a balanced ETV1
rearrangement in MDA-PCa 2b). Gene expression analyses of
VCaP cells in Matrigel indicated that the cells may undergo
terminal differentiation or senescence when embedded in Matrigel
(data not shown). Expression of the TMPRSS2-ERG fusion gene
and proliferation-relevant genes was reduced in Matrigel. However,
growth of VCaP and DuCaP was not restricted in collagen type I
gels; and gene expression patterns in Col I were limited (not shown).
Dynamic changes of gene expression in response to
Matrigel correlate with normal, transformed and invasive
properties
LrECM and the formation of spheroids induce fundamental
changes in cell biology, protein and mRNA gene expression of
PrCa cells. About 3400 mRNAs were differentially expressed
between 2D and 3D conditions, however not consistently across all
cell lines and all time points. Three generalized patterns of altered
gene expression were observed across the panel of cell lines
(Figure 4a+b). Altered expression of selected genes was validated
by qRT-PCR (Figure 4c). Factors of differential expression, as
confirmed by qRT-PCR, were generally greater compared to the
array data. GO analyses and GSEA revealed highly significant
enriched functional gene categories for most of the clusters (Tables
S4, S5 and S6).
a) Non-transformed cells. Genes whose response to 3D
Matrigel culture (cluster 1+2; Figure 4a; Table S4) was restricted
to non-transformed cells were mainly related to ECM turnover,
lipid and eicosanoid/prostaglandin metabolism, or cell
differentiation. These gene sets are likely to be required for both
normal spheroid maturation and acinar branching, and include
known regulators of epithelial differentiation, cell migration and
acinar morphogenesis such as WNT5A [36,37] and the basal-type
cytokeratins suchas KRT5 and KRT14. A number of these genes
were associated with basal epithelial differentiation patterns. In
contrast, PrCa cells preferentially show luminal differentiation.
b) Generalized Effects of Matrigel on Gene
Expression. Gene sets that homogeneously respond to lrECM,
regardless of the cell line, transformation status or spheroid
morphology fell into 3 clusters: Cluster 7 (repressed) was highly
enriched in mitochondrial and ribosomal functions, mRNA
processing, and general metabolic processes, indicating the overall
reduced growth, metabolic activity and proliferation of cells in 3D
compared to monolayer culture. Similarly, cluster 8 showed an
extremely significant (p,10257) enrichment of cell-cycle, DNA-
synthesis, mitosis, and proliferation processes, confirming the general
reduction of cell proliferation in response to lrECM. However, the
average fold change (Figure 4b) observed for these genes ranged
between 1.5 to 2 fold; indicating that cells in 3D culture continue to
replicate, however more slowly compared to 2D. Normal PrEC’s
continue to proliferate in lrECM somewhat longer compared to
PrCa lines; this effect has also been described for primary mammary
epithelial cells [18]. Cluster 6 was highly enriched in genes related to
lipid/steroid metabolism (p,10211), chromatin modification and
epigenetic re-programming (p,1027), pointing to profound
epigenetic changes involved in acinar differentiation.
c) Invasive transformation. Gene sets expressed in stellate
or induced during the morphological transformation of round PC-3
spheroids into stellate structures (cluster 9) were enriched in GO
terms related to cell adhesion, cell-cell contact, invasion/metastasis,
and ECM turnover (collagens, laminin isoforms, integrins ITGB2,
ITGB4, ITGAV, ITGA1 and ITGA10; Table S4). This cluster also
contained many early developmental transcriptional regulators
(CITED2, HEY1, SOX4, SOX9, FOXO3, HOXA13, HOXB13,
qRT-PCR validation in Figure 4c). Cluster 11, showing strong
induction of genes in both invasive PC-3 and branching RWPE-1
cells, contained mainly interferon-inducible genes (OAS1, OAS2,
MX1, IFI27, STAT1, STAT2 etc). This may suggest a dual role of
IFNs a/b, STAT1/STAT2 transcription factors and inflammatory
processes in both invasion and branching of non-transformed
epithelial cells (RWPE-1).
Principal Component Analysis: mRNA gene expression
signatures of cell lines correlate with the Morphology in
3D
Principal component analysis (PCA, Figure 5a) was used to
identify the most characteristic gene signatures that may
distinguish spheroids of normal/round (PrEC, EP156T, and
RWPE1), mass (LNCaP and 22rV1) and stellate morphologies
(ALVA31, PC3, PC3M, RWPE-2/w99). The basal keratins
KRT5, KRT6A-C, KRT13, KRT14, and KRT17 represent the
most representative genes for round spheroids, characteristic for
the basal-like phenotype of in-vitro immortalized lines and normal
prostate-epithelial cells. Luminal markers such as keratins KRT8
and KRT18 were only poorly expressed (Table S3), but
inflammatory chemokines such as interleukin 1a and IL1b were
also characteristic. In contrast, luminal differentiation-related and
androgen-inducible genes such as NKX3-1, SYT4, KLK4, CK18,
and TMSL8 were identified as the most characteristic markers for
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Figure 4. Characteristic patterns of altered mRNA gene expression of cells cultured in laminin-rich ECM (Matrigel), compared to
monolayer culture (ratios 3D/2D). A) Heatmap, illustrating 12 clusters generated by the K-means algorithm. Clusters 1+2 represent genes
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the mass phenotype, which represents the majority of PrCa cell
lines. Genes such as CTGF (connective tissue growth factor) or
PLAT (tissue-type plasminogen activator) were most characteristic
for invasive cell lines like PC-3 or RWPE-2/w99; indicating a
possible role of TGF beta signaling, active remodeling of the
ECM, and mesenchymal properties during invasion [38]. Further
analysis of the genes most strongly associated with invasive/stellate
phenotype, using Ingenuity Pathway Analysis (IPA), resulted in
multiple gene networks, including one that illustrates an
association with the AKT pathway and signaling through various
G-protein coupled receptors (G alphai proteins), chemokines-
receptor CXCR4, the invasion- and angiogenesis related Neuro-
pilin (NRP1) and the neuropeptide apelin (APLN). Other
connected genes were the cytoskeletal proteins zyxin (ZYX) and
nebulette (NEBL), ECM-related genes EFEMP2 (EGF-containing
fibulin-like extracellular matrix protein 2), rhophilin (RHPN) and
FAM107A, and the transcription factors FOXO3 and TCF4
(Figure 5b). Although the basal lamina of invasive, stellate
structures becomes increasingly fuzzy and disintegrated, invasive
PC-3, PC-3M and ALVA31 cells continued to secrete a different
panel of laminins. While laminin-5 (a3b3c2), associated with
normal epithelial differentiation, was re-induced at early time
points in PC-3 cells growing in 3D culture, other laminins subunits
(a5, b2, c1) were de-novo expressed after transformation (Fig 5c),
as validated by immune fluorescence (Figure 5d, LAM-89 pan-
laminin antibody).
A role for Epithelial-to-Mesenchymal Transition (EMT) in
invasion and the stellate phenotype?
The cell lines with the most prominent latent, invasive potential
(ALVA31, PC-3 and PC-3M), to some degree shared by the
heterogeneous RWPE-1 and RWPE-2/w99 cells, showed the
exclusively affected in normal cells (PrEC, EP156T). Clusters 6–8 represent genes similarly induced or repressed in all cell lines in response to 3D cell
culture in Matrigel 3D, regardless of phenotype, or transformation. Clusters 9–12 contain genes characteristic for the stellate/invasive type cell lines
(ALVA31, PC3, PC3M, RWPE2/w99), or which are induced during the spontaneous conversion of round to stellate structures (e.g. PC3, day 13 and 15).
B) Average expression changes, illustrating the median (dark grey) and variation (light grey) of altered gene expression within clusters. C) QRT-PCR
analysis (black) and Illumina array data (grey) for a selected panel of genes, validating increased expression in invasive PC-3 cells.
doi:10.1371/journal.pone.0010431.g004
Figure 5. Functional analysis of altered gene expression data in 3D culture, compared to 2D monolayer. A) Principal component
analysis (PCA), illustrating gene sets that distinguish round, mass-, and stellate morphologies. Round phenotype cells included were PrEC, EP156T,
and RWPE1. The mass phenotype is represented by LNCaP and 22rV1 cells. Stellate/invasive cells comprise ALVA31, PC3, PC3M, and RWPE-2/w99. B)
Ingenuity Pathway Analysis (IPA) of invasion-related clusters 9–12 (Figure 4), illustrating network 2 out of 13 generated. This network is centered on
the AKT and PI3-Kinase pathways. Colors correlate to factors of differential expression observed between round and invasive spheroids (red: induced,
green: repressed). C) Heatmap, illustrating altered mRNA expression of laminins in 2D and 3D culture. Expression of laminins a5, c1, b2 and a3 is
strongly induced in the invasive transformation of PC-3 and PC-3M cells (days 13+15). D) Continuous expression of various laminins after onset of
invasion, as demonstrated by staining with a human-specific antibody (LAM-89) that detects various alpha and beta subunits.
doi:10.1371/journal.pone.0010431.g005
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highest expression of mesenchymal markers (Vimentin VIM,
Fibronectin FN1, N-cadherin CDH2 (Figure S3a), CDH11 (Figure
S3b), and loss of expression of epithelial markers such as E-
cadherin CDH1 (Figure S3c). Simultaneously, mesenchymal and
epithelial cadherins were co-expressed in RWPE-1 cells (CDH1
and CDH2; Figure S3a). This indicates that these cells (or
subpopulations e.g. within RWPE-1; Figure S3c) may have
undergone an epithelial-mesenchymal transition (EMT), possibly
in vitro. This observation is further supported by the homozygous
deletion of catenin alpha-1 (CTNN1A) in PC-3 and PC-3M, a
gene that cooperates with E-cadherin in formation of epithelial
cell-cell-contacts (not shown). The loss of PTEN (phosphatase and
tensin homolog) in PC-3, PC-3M and ALVA31 cells may have
also contributed to this EMT [39,40] and the concomitant
activation of AKT and PI3 Kinase pathways. However, many
mesenchymal marker genes (VIM, FN1) and EMT-related
transcription factors (e.g. Slug, SNAI2) were strongly expressed
in both 2D and 3D culture, remained unchanged throughout all
stages of spheroid formation, and were not significantly induced in
the invasive transformation of PC-3 spheroids (Figure 3s).
Additionally, VIM and FN1 were also expressed in non-
transformed RWPE-1 and non-invasive DU145 cells (Figure 3o–
y). Slug (SNAI2) shows the highest expression in non-invasive cell
lines and may be required for normal prostate differentiation
(Figure 5a; Figure S3b). TWIST1 expression correlates more
consistently with the EMT-related observations.
High level EMT marker expression may indicate a latent or
metastable EMT phenotype, which is temporarily repressed by the
lrECM in favor of normal epithelial differentiation. Eventually,
mesenchymal phenotypic features prevail, overriding epithelial
differentiation patterns which may then result in cell invasion. In
contrast to the EMT/mesenchymal markers, many genes
downstream of AKT and related cancer-relevant pathways (PI3-
Kinase, PTEN, IGF1R, mTOR and S6 Kinase) are induced when
PC-3 and PC-3M cells become invasive (Figure S4a–c). Among
others, these prominently include the invasion-related integrins
alpha 10, beta 4, and beta 2; many laminins and collagen subunits
and the interleukins IL10 and IL23A. Clinical gene expression
data (Figure S4d) [41] validated that invasion- and AKT/PI3-
Kinase associated genes, as exemplified by collagen 1 alpha 1, may
also be up-regulated in PrCa compared to normal prostate, and
may correlate with high Gleason grade tumors.
Pathways, key regulatory proteins and molecular
mechanisms correlate with spheroid formation and
invasion
Key pathways for the formation of round and mass spheroids, in
comparison to 2D/monolayer culture, were identified by a
combination of multiple bioinformatic approaches, including
Principal Component Analysis (PCA), Ingenuity Pathway Analysis
(IPA), Gene Ontology annotation (GO), and Gene Set Enrichment
Analyses (GSEA).
Round and mass phenotype. The pathways most relevant
for the formation of both round and mass spheroids in 3D were
primarily related to lipid and steroid metabolism, prostaglandins/
eicosanoids, and epigenetic regulation of gene expression. (Tables
S5 and S6) Of the key signaling molecules identified, IGF1/IGF2
receptor, NFkB, pro-inflammatory chemokines (IL-1a, TNFa and
CCL2), and AKT and PI3Kinase were suggested as the most
prominent. The expression of NFkB1 (p50, p105); IKKa, STAT1
and p-STAT1 (but not STAT2); or Smad-3 were consistently
reduced in spheroids compared to 2D (Figure 6a). This pattern is
in agreement with temporarily increased levels of inhibitory IkBa
and IkBe proteins (Figure 6b), peaking around days 6–8 of
spheroid formation. This suggests the tight control of pro-
inflammatory processes and chemokines/cytokines (e.g. CCL2)
particularly at early stages of spheroid formation, but not in
invasive structures. Lysate array analysis of phospo-GSK3b
expression showed very similar dynamics (not shown), further
supporting the temporary repression of both NFkB and Wnt
signaling pathway during critical stages of spheroid formation.
Invasive/stellate phenotype. Core pathways identified in
invasive cells (Figure 7a, Tables S5 and S6) were most prominently
related to AKT and PI3Kinase, integrins, laminins, TGFb, JAK/
STAT & interferon signaling, hedgehog signaling, and matrix
metalloproteinases (MMP13). Increased levels of pAKT1
compared to 2D conditions (both p-Ser308 and p-Ser473) were
detected in most mass- and invasive-, but not in normal spheroids
(Figure 6a). In invasive PC-3 cells, levels of these proteins were
further increased. The expression of transcriptions factors STAT1
& STAT2, concomitant with interferon-inducible genes such as
IFITM1 (interferon-inducible transmembrane protein 1), OAS1 or
IFI27, point to the activation of JAK/STAT and interferon a/b-
related signaling pathways in invasive cells (Figure 7a,b+d) as
validated by immune fluorescence (Figure 7c) Since the expression
of interferon-related genes and pathways was similar in both
strongly branching RWPE-1 and invasive RWPE-2/w99,
ALVA31, PC-3 or PC-3M cells, we postulate a general role of
these mechanisms in cell motility.
Compounds targeting AKT, PI3Kinase, and mTOR inhibit
invasion in spheroid cells
Our miniaturized 3D culture system with a well-in-a-well
microscopic format (15 experiments/plate), complemented with a
high-content live-cell imaging system, and quantitative image
analysis software, was developed for larger-scale compound testing
in 3D. A library of .100 compounds was collected according to
IPA, DrugBank, and Matador (Table S7), based on specific target
genes or pathways/key signaling molecules suggested by Ingenuity
pathway analysis. Compounds were first tested against ‘‘stellate’’
spheroids formed by PC3 and PC-3M cells, to identify inhibitors
that may specifically block invasive tumor cells (Figure 8a+b). PC3
cells were also treated in monolayer culture (Figure 8c). Effective
inhibitors identified were then further tested against a larger panel
of cell lines in 3D, including non-transformed EP156T and
RWPE-1 cells, and non-invasive DU145, LNCaP and 22rV1 cells
(Figure S5). Small molecule inhibitors targeting PI3-Kinase
(NU7026, APB2) and the AKT pathway (deguelin, API-2) most
selectively inhibited invasion, proved less effective in 2D
monolayer cultures,. The same inhibitors had only mild or no
effects on normal cells. In contrast, most compounds targeting the
mTOR and IGF1R pathways equally inhibited both invasive and
non-invasive spheroids, normal cells in 3D, or cancer cells in
monolayer cultures. Inhibitors against Hedgehog signaling (e.g.
cyclopamine) also inhibited growth of both normal and cancer
cells. In contrast, inhibitors targeting NFkB, pro-inflammatory
chemokines & receptors (IL-1a and CCL2), TGFb, p38 or p42/
44MAP kinases were consistently ineffective against invasive and
normal cells. Surprisingly, HDAC inhibitors and anti-mitotic
drugs were ineffective, even at concentrations that were previously
shown to cause apoptosis in monolayer culture [42].
Discussion
We have characterized growth, differentiation and genome-
wide mRNA expression patterns for a large panel of normal, non-
transformed and prostate cell lines in Matrigel, covering all classic
and many novel PrCa cell lines [43]. The development of
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Figure 6. Altered expression of key signaling molecules, phospho-proteins and transcription factors in 2D versus 3D culture. A) Western
blot analysis of various transcription factors (AKT1, STAT1, STAT2, IKKa, NFkB1 p50, SMAD3), androgen receptor (AR) and PCNA. B) and C) Protein lysate
analysis of IkBa and IkBe (inhibitor of NF-kappaB) in cell lysates isolated from cells grown as monolayer in 2D or as spheroids in 3D culture. D) Lysate array
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miniaturized and cost-effective 3D models enabled us to monitor
growth, maturation, invasion and motility of prostaspheres in real-
time and high resolution, by combined live cell and confocal
microscopy. These models will facilitate higher-throughput
compound screens in 3D, allowing quantitative measurement of
growth, size, shape, cellular dynamics and morphology of acinar
structures. Recent research activities have mainly focused on the
role of stem/progenitor cell populations in spheroids [39,44],
reviewed in [45]. With very few exceptions [46], these studies refer
to prostaspheres cultured under anchorage-independent condi-
tions, lacking any contact to ECM [47]. In contrast, our
differentiation-related models showed essentially no enrichment
of stem cell markers. It is clear and expected that lrECM primarily
supports differentiation, but we were surprised that Matrigel is
able to trigger normal-like epithelial differentiation programs even
in PrCa cell lines that have been in vitro culture for over three
decades. This essentially confirms the concepts formulated by
Mina Bissell two decades ago, that context and in particular tumor
environment matters and may powerfully override [48] malignant
genotypes. However, our experimental data show that repression
of the tumorigenic phenotype may also be only temporarily.
The specific aim of this study was a detailed analysis of various
different modes of growth, migration and invasion of normal and
prostate cancer cells, and the identification of small-molecule
inhibitors that may specifically block invasive behavior. This is the
first study describing the dynamic reversion of polarized epithelial
spheroids into invasive cells, and gene co-expression networks
associated with this transformation. While cell invasion and
motility are traditionally analyzed by Boyden chamber, transwell
or two-dimensional would-healing assays, our system provides a
analysis of proliferation marker Ki-67 and cleaved PARP, a marker for apoptosis. Relative ratio of specific antibody signal to overall b-actin signal was used
for data normalization, allowing relative quantitative comparisons between cell lines, time points, and growth conditions.
doi:10.1371/journal.pone.0010431.g006
Figure 7. Functional analysis of dynamic gene expression changes observed in PC-3 cells, which correlate with the morphologic
transformation of round to stellate spheroids. A) Principal component analysis PCA. Genes highlighted by arrows correlate best with PC-3 cells
in monolayer (2D) culture, or round (day 4+ 8) and stellate phenotype (day 13+15) in 3D. B) IPA gene network analysis illustrating cross-talk between
STAT1/STAT2, interferon a/b, and NFkB signaling in invasive cells (colors indicate factors of altered expression; red = induced, green = repressed). C)
Immune staining of JAK1 and STAT2 protein expression in stellate PC- 3 spheroids. STAT2 signal is highest in invasive structures, JAK1 in peripheral
cells. D) IPA: Schematic representation of Interferon c and a/b signal transduction pathways, colors corresponding to fold changes of gene expression.
doi:10.1371/journal.pone.0010431.g007
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unique system to monitor and modulate invasive processes in an
organotypic environment. Characterization of altered gene
expression in spheroids and particularly invasive cells confirmed
the importance of AKT and PI3-Kinase pathways in mammo-
sphere- or prostasphere growth [39,49–51]. However, AKT and
PI3K pathways were shown to be particularly critical for invasion:
Most drugs targeting these pathways effectively blocked aggressive
invasion processes, but were less potent in 2D conditions, and
often minimally affected growth and branching of normal cells. In
contrast, mTOR, IGF1R and JAK/STAT pathways appeared to
be primarily important for growth, branching and differentiation
of both normal and tumor cells, regardless of the cell culture
conditions, ECM and the microenvironment. Induction of JAK/
STAT signaling, as reflected by the expression of many interferon-
inducible proteins, may represent a general feature of migratory
cells, and was observed in both branching and malignant invasive
cells. Inflammation-related pathways [52] seemed less relevant for
either growth or invasion. Compounds inhibiting the NFkB
pathway were largely ineffective, in line with the observation of
reduced expression of NFkB1, IKKa and increase of NFkB
inhibitors IkBa, IkBe and IkBf in maturing spheroids. Further-
more, although expression of pro-inflammatory chemokines
(CCL2, IL-1a, TNFa) was induced in spheroid formation,
compounds targeting the corresponding receptors proved ineffec-
tive. Most drugs inhibiting cell cycle progression/mitosis, p38 and
p42/44 MAP kinases, or matrix metalloproteinase’s (MMPs) were
also ineffective against invasion, with the exception of WAY-
170523, a specific inhibitor of MMP13 [53].
The pattern of invasion observed in aggressive PC-3 and PC-3M
cells can be best described as streaming or chain migration [23,24],
and only occasionally single cells move by themselves. Invading
cells transiently form and resolve cell-cell contacts, while moving
along a common track through the ECM. The simultaneous
induction of integrins such as ITGB2, ITGB4 and ITGA10, a
panel of collagens and many other extracellular proteins indicates
the importance of dynamic cell-matrix adhesion and attachment
forces in this type of invasion. The over-expression of some of these
markers in high grade PrCa may indicate that similar mechanisms
Figure 8. Exemplary response of spheroids from normal (EP156T) and invasive prostate cancer cells (PC-3) to the drug NU7026, a
small molecule inhibitor specifically targeting PI3-kinase. A) Live-cell imaging of normal (EP156T) and invasive (PC-3) spheroids, treated with
NU7027. B) Immune fluorescence of NU7026-treated EP156T and PC-3 spheroids, using an antibody targeting laminin b1 (green) and Alexa488-
coupled phalloidin (F-actin). DAPI was used for nuclear staining. Drug exposure blocks the transformation of PC-3 spheroids into the stellate
phenotype, but does not affect formation of normal spheroids. Vehicle-only (0.1% DMSO) served as a control. C) Lack of response of PC-3 cells to
NU7026 (72 h) in monolayer culture (CTG, Cell Titer Glo assay). D) Quantitation of size (area, total # of pixels) and # of appendages (invasive
structures, median length in pixels) in treated vs. untreated PC-3 spheroids. Bars represent the standard error.
doi:10.1371/journal.pone.0010431.g008
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and genes also play a role in vivo. Furthermore, dynamic actin
polymerization-depolymerization cycles and Rho/Rac-mediated
control of cell protrusion may be required for propelling migratory
cells [33,54]. Collective chain invasion is very different from the
sheet- or tube-like movement observed in branching acinar
morphogenesis of normal cells - a hallmark of normal organ
development - and generally more dynamic. It is also different from
amoeboid or gliding patterns of movement more commonly
observed in 2D cultures.
The re-expression of epithelial markers such as laminin-5 [55],
and the tight-junction protein Cx43 (GJP1) in invading cells is
contradicting some previous reports in prostate [51], breast and
ovarian cancers [9,56], but it is consistent with the dynamic
formation and resolution of cell-cell contacts in streaming
invasion. Specific laminins may be required for lubrication and
maintenance of tracks utilized as channels for invasion through the
ECM. Guiding cells, referred to as ‘‘guerilla cells’’, may provide
overall orientation and direction (reviewed in [57]). The question
whether fibroblasts may serve as guide cells remains to be
elucidated [27]. In our models, guide cells can be identified by
sharp, elongated and spindle-like filopodia, formed prior to the
onset of invasion.
In addition to the re-expression of epithelial markers in invasive
cells, streaming invasion is not considered a characteristic for
mesenchymal cells or epithelial cells that have undergone an
EMT. These are traditionally thought to migrate as single cells in a
fibroblast-like fashion. Although an EMT genotype was indicated
by the expression of mesenchymal markers, we were not able to
define a clear mesenchymal, invasion-related phenotype. Further-
more, the invasive cells lacked prominent stem-cell related
expression signatures [58] and did not acquire properties of CSCs
(e.g. CD44+/CD242). In contrast, expression of mesenchymal
markers was a common feature in many cell lines and not causally
related to malignant transformation nor invasiveness [59].
Mesenchymal markers are detected in branching (RWPE-1),
round (DU145) and all stellate (RWPE-2/w99, ALVA31, PC-3,
PC-3M), but not in mass-phenotype spheroids (e.g. LNCaP,
22rV1) with a prominent luminal phenotype. Round, early stage
PC-3 and PC-3M spheroids expressed mesenchymal markers
Vimentin and Fibronectin, which remained at the same expression
levels even after the invasive conversion. Vimentin was co-
expressed with epithelial markers such as cytokeratins 5 and 14 or
E-cadherin in round spheroids, which did not interfere with
epithelial polarization and differentiation (DU145, PC-3). Nuclear
translocation of b-catenin and associated Wnt pathway induction,
another hallmark of EMT [60], were not observed in invading
cells. Of the classic E-box binding transcription factors associated
with EMT, only expression of TWIST1 [61,62] and ZEB1
correlated with the invasive potential of cell lines. None of these
genes were further induced upon cell invasion. Surprisingly, Slug
(SNAI2) expression was repressed during invasion, but strongly
expressed in normal spheroids–suggesting a role in epithelial
differentiation instead of EMT.
EMT as a developmental mechanism could be involved in
normal developmental processes and invasive cancers alike, and
likely represents a bidirectional process (EMT versus MET) [63]. In
cancers, EMT might simply be a sign of increased tumor cell
plasticity, rather than a key mechanism that provides invasive
properties per se. Meta-stable and phenotypic flexible cancer cells,
having undergone an EMT, are still capable of epithelial
differentiation. This may be particularly relevant for the survival
of micro-metastases in the blood stream, successful tissue
colonization, and the formation of distant metastases [33]. It is
interesting to note that despite the lack of both E-cadherin and
alpha catenin, PC-3 cells are still able to form epithelial cell-cell
contacts, apparently using alternative mechanisms which may not
be a specialty restricted to this cell line. Further investigation of
dynamic transformation of epithelial into invasive cells (and the
reverse) may provide more general insights into these mechanisms,
and the putative role of EMT. Recent reports confirm a possible
function of EMT in mixed sheet- and chain migration patterns for
various cell types [64,65]. Expression of invasion-associated markers
and pathways (AKT, PI3 kinase, STAT1), identified in our in vitro
models, will be further investigated in clinical tumor samples, with a
focus on high grade, metastasizing and invasive cancers.
In summary, our experimental systems facilitate the investiga-
tion of polarized epithelial structures or spheroids which mimic
morphology, biochemistry, and invasive processes of tumors in
vitro. We and others [26,28] have shown that breast- and PrCa cell
lines in 3D are representative for many questions relevant to
tumor cell biology, rather poorly addressed in monolayer cell
cultures. These 3D models can be useful and more reliable for
cancer drug discovery and target identification, particularly if
reproducibility and quantification of the relevant assays are
properly addressed.
Our models provide comparatively low cost, high throughput in
vitro tools for cancer research and drug discovery, allowing complex
cell biology questions to be explored experimentally, and may
partly reduce or replace animal xenograft models. 3D models
could therefore serve as an intermediate decision-making step in
the pre-clinical drug development pipeline, linking large scale high-
throughput compound screens for lead identification and increas-
ingly expensive validation studies based on animal xenografts.
Supporting Information
Figure S1 Morphologically different multicellular structures are
formed after embedding non-transformed/immortalized EP156T
cells and PrCa cells (cell lines DU145 and PC-3) into purified
collagen (left panel, PureCol; rat-tail collagen I), or growth-factor
reduced Matrigel (right panel). Structures were imaged by phase-
contrast microscopy (right side of each panel), and stained with
Alexa488-conjugated phalloidin to highlight the cytoskeleton
through F-actin (left side).
Found at: doi:10.1371/journal.pone.0010431.s001 (6.22 MB TIF)
Figure S2 Representative confocal laser scanning images of
spheroids formed in 3D Matrigel culture, stained with an antibody
against laminins beta 1 (LAMB1) to highlight the formation of a
basal lamina (BL) surrounding the structures formed in Matrigel.
Round structures invariably have a complete, robust BL
surrounding the entire spheroid. Mass phenotype spheroids have
often thin, heterogeneous, and incomplete BL. Stellate structures
show variable, often fuzzy BL structures, with a thin BL also
surrounding the invasive cells. Grape-like structures do not have
any recognizable BL. Single phenotype cells show spotty, irregular
expression of laminins.
Found at: doi:10.1371/journal.pone.0010431.s002 (7.45 MB TIF)
Figure S3 Analysis of markers and transcription factors related
to epithelial-mesenchymal transition (EMT). A) Expression of
epithelial-specific cadherin CDH1 (E-cadherin) versus mesenchy-
mal-specific cadherin CDH2 (N-cadherin) across all cell lines, in
monolayer and 3D culture. CDH2 is highly expressed in PC-3 and
PC-3M, and co-expressed with CDH1 in RWPE-1 cells. B)
Normalized gene expression values for a panel of epithelial- and
mesenchymal-specific cadherins and EMT-related transcription
factors in PrCa cell lines, as detected by Illumina bead arrays. C)
Expression of CDH1 (E-cadherin) in spheroids formed by non-
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transformed, hTERT immortalized EP156T cells (strong and
homogeneous), immortalized RWPE-1 cells (heterogeneous,
strong in round structures but negative in branching acini), and
PC-3 (negative).
Found at: doi:10.1371/journal.pone.0010431.s003 (2.85 MB TIF)
Figure S4 Functional analysis of gene expression patterns,
utilizing gene signatures associated with the six most closely
related, prostate-cancer relevant pathways (AKT, PI3-kinase,
IGF1 receptor, mTOR, S6 kinase, and PTEN). A) Composition
of gene signatures, according to compilations by Biocompare
(www.biocompare.com). B) Venn diagram, demonstrating over-
laps between AKT, PI3-kinase, and mTOR pathway-associated
genes. C) Heatmap, highlighting the expression of the most
strongly invasion-related, up-regulated genes from combined
pathway analyses in PC-3 cells, after transformation of round
into stellate spheroids. D) Exemplary expression of collagen 1
subunit A1, in PrCa microarray samples analyzed through the
expO gene expression consortium (www.intgen.org), indicating a
positive association of expression with clinical parameters such as
advanced stage, high grade tumors, and high Gleason score. The
insert illustrates the relative expression of COL1A1 mRNA in
normal prostate compared to prostate cancers (IST database,
www.genesapiens.org).
Found at: doi:10.1371/journal.pone.0010431.s004 (1.93 MB TIF)
Figure S5 Quantitative analysis of inhibitory drug effects on
spheroid growth (area in pixels) for a panel of normal, non-
transformed and cancer cell lines, using VTT ACCA image
analysis software. Drugs, effective concentration, and major
pathways inhibited by the compounds are indicated in the figure
(text box).
Found at: doi:10.1371/journal.pone.0010431.s005 (1.02 MB TIF)
Table S1 Cell lines and models used in this study.
Found at: doi:10.1371/journal.pone.0010431.s006 (0.07 MB
DOC)
Table S2 Antibodies used in this study.
Found at: doi:10.1371/journal.pone.0010431.s007 (0.06 MB
DOC)
Table S3 Summary of immune staining results for spheroids
formed in 3D Matrigel culture.
Found at: doi:10.1371/journal.pone.0010431.s008 (0.10 MB
DOC)
Table S4 Gene Ontology Annotation for Gene Expression
Clusters 1–12. Only the most significant enrichment factors and
false discovery rates (FDR) are shown.
Found at: doi:10.1371/journal.pone.0010431.s009 (0.18 MB
DOC)
Table S5 Gene Set Enrichment Analysis GSEA, (A) for genes
differentially expressed genes in monolayer vs. 3D spheroid culture
in Matrigel, across all 10 cell lines analyzed, and (B) GSEA for
differentially expressed genes in PC3 cells, comparing round (day
4+8) with stellate morphology (day 13+15).
Found at: doi:10.1371/journal.pone.0010431.s010 (0.16 MB
DOC)
Table S6 Ingenuity Pathway Analysis (IPA) for genes differen-
tially expressed between 2D monolayer and 3D spheroid culture in
Matrigel (general effects, 10 cell lines), and B) IPA for differentially
expressed genes in PC3 cells, comparing round (day 4+8) with
stellate morphology (day 13+15).
Found at: doi:10.1371/journal.pone.0010431.s011 (0.06 MB
DOC)
Table S7 Summary of small molecule inhibitors and drug
treatments used in this study, directed against canonical pathways
identified by functional gene expression analyses. Abbreviations:
IB = invasion block; IAM = impaired acinar morphogenesis;
GR = growth reduction; GA = growth arrest; CD = cell death.
Found at: doi:10.1371/journal.pone.0010431.s012 (0.16 MB
DOC)
Movie S1 Time lapse movie generated from live cell images
(1 image/h), showing the formation of round spheroids by PC-3
cells. Movie sequence starts around day 8 after seeding into
Matrigel. Round spheroids are then transformed into stellate
structures, starting at approx. days 11–13 after inoculation.
Found at: doi:10.1371/journal.pone.0010431.s013 (10.55 MB
MP4)
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